Olfactory groove meningioma
Introduction:
Meningiomas are
benign and rather slow growing tumor arising from arachnoidal cap
cells. Statistically speaking meningiomas constitute about 20% of
all primary intracranial tumors. Out of these 20% olfactory groove
meningiomas constitute 10%. It was the Italian surgeon Francesco
Durante who first reported the first successful resection of
olfactory groove meningioma in 1885. In 1938 Cushing reported the
largest series of olfactory groove meningioma which were resected via
frontal craniotomy / subfrontal approach. It is really worthwhile to
differentiate olfactory groove meningioma from other intracranial
menigiomas as they differ in their presentation, symptomatology and
management.
Sex ratio:
The female :
male ratio is 2:1. Exact explanation for this variation is not
available.
Pathophysiology:
Meningiomas
arise from meningothelial cap cells that are largely distributed
through the arachnoid trabeculations. The greatest concentration of
meningothelial cells are seen in the arachnoid villi lining the dural
sinuses, cranial nerve foramina, middle cranial fossa and cribriform
plate area. This accounts for the common location of meningiomas
i.e. Over the convexity, along the skull base and along the falx.
Meningiomas are usually attached to the dura and are well
encapsulated. Blood supply to these tumors arise usually from the
dura and the anterior and posterior ethmoidal arteries.
Histology:
Histologically
these tumors show features of bening lesions. These lesions
classically appear as whorls of arachnoid cells surrounding a central
hyaline material that eventually calcifies. These calcified areas
are known as Psammoma bodies. These cells are arranged in sheaths
separated by connective tissue trabeculations.
Subtypes of
meningiomas:
Meningotheliomas
Fibrous types
Transitional
types – Psammamatous tumors
Secretory
meningiomas – Secretes Vascular endothelial growth factor. These
tumors are characterized by the presence of marked oedema. They may
be papillary or rhabdoid variants. These tumors are usually
considered to be malignant in nature.
WHO
histological grading of meningiomas:
Grade I: This
grade is usually benign and 90% of all meningiomas belong to this
category. They also carry the best prognosis and a very low
recurrence rate.
Grade II:
Atypical meningiomas come under this category. About 5% of all
meningiomas belong to this grade. Tumors belonging to this grade
have a high recurrence rate (about 50%).
Grade III: This
grade of meningioma is frankly malignant constituting about less than
3% of all meningiomas.
Molecular
biology:
Majority of
meningiomas are associated with one / more focal chromosomal
deletions. Malignant versions of meningiomas involve multiple
chromosomal aberrations. These multiple chromosomal abberations
cause extreme instability to the genomic structure thereby increasing
the risk of malignant transformation.
Deletion and
inactivation of NF2 gene on chromosome 22 is the predominant feature
in sporadic meningiomas.
Risk factors
contributing to meningioma:
Exposure
to ionizing radiation – Studies have demonstrated that survivors
of atom bomb explosion showed increased incidence of meningioma
Role of
Hormones – Histologically meningiomas present with oestrogen,
progesterone and androgen receptors. This could explain the
increased incidence of menigioma in females.
Head
injuries have been shown to increase the incidence of meningiomas.
Location of
olfactory groove meningioma:
These tumors
are seen in the midline and arise over the cribriform plate and
frontosphenoidal suture area. A majority of these tumors occupy the
floor of anterior cranial fossa extending from crista galli up to the
tuberculum sella. Extension to ethmoidal sinuses occur in about a
third of these patients. There are obvious similarities existing
between posteriorly extending olfactory groove meningiomas and
tuberculum sellae meningiomas. These two masses can be
differentiated by studying their relationship with that of the optic
apparatus. Olfactory groove meningiomas have a tendency to push
optic nerves and chiasma downwards and posteriorly as they grow,
where as tuberculum sellae meningiomas push the optic nerves and
chiasma upwards and superolaterally as they grow because of their
subchiasmal position.
Blood supply of
olfactory groove meningiomas:
These tumors
are supplied by:
Anterior
ethmoidal artery
Posterior
ethmoidal artery
Anterior
branches of middle meningeal artery
Meningeal
branches of ophthalmic artery
Clinical
features:
These tumors
are very slow growing ones and they are seen in the silent area.
Hence to become symptomatic they need to enlarge their size to a
great extent. Usually these lesions are incidental findings during
routine imaging.
MRI is the most
preferred imaging modality as this would clearly show the origin of
the tumor from dura. These lesions appear isointense / hypointense
to gray matter of brain in T1 weighted images and isointense to
hyperintense in T2 weighted images. When gadolinum is used as
contrast these lesions demonstrate homogenous enhancement.
Majority of meningiomas show marginal
dural thickening that tapers peripherally. This tapering is
classically known as the dural tail which is the characteristic
feature which is revealed in the images.
Management:
This entirely depends on the age and
physical fitness of the patient. If the tumors are small and seen in
elderly and ill patients then serial imaging and observations would
do. In symptomatic cases irradiation can be resorted to,
Surgical resection is the best option.
Removal of these lesions is similar to that of any other skull base
tumor.
Surgical management:
Cushing was the first to describe
surgical resection of the tumor via unilateral frontal craniotomy.
Other approaches available include:
Bifrontal craniotomy
Subfrontal approach
Pterional approach
Endoscopic approach
Bifrontal craniotomy combined with
subfrontal approach: This approach provides wide exposure for
complete removal of tumor. In this approach it is easy to drill out
the hyperostotic area in the cribriform plate area. In this approach
optic nerves also can be deroofed if need be. Major disadvantage of
this approach is the amount of brain retraction that is needed.
Unilateral frontal craniotomy with
subfrontal approach: This approach has the advantage of sparing the
opposite frontal lobe and superior saggital sinus. The disadvantages
include:
Smaller exposure
Excessive brain retraction
Pterional approach:
This is a rather new approach. It is
less invasive than frontal craniotomy approaches. It avoids CSF
leaks because the frontal sinus is not damaged. The optic nerve can
be localised and exposed before tumor manipulation. Major
disadvantage of this approach is the lack of working space. The
wole dissection process needs to be carried out within a narrow
angle.
Endoscopic resection:
This procedure is performed binaurally
with the endoscope introduced through one nose and the surgical
instruments via the other.
This procedure involves:
Bilateral maxillary antrostomies
Complete ethmoidectomies
Sphenoidotomies
Frontal sinusotomy
Unilateral / bilateral nasal septal
flaps are harvested first. This helps in covering the dural
defect.These flaps are tucked into the nasopharynx well out of the
way of surgical field.
Modified Lothrop procedureis performed.
The frontal intersinus septum should be completely removed.
Controlling the bleeding to the mass is
the top most priority. The anterior ethmoidal artery should be
identified and ligated. Anterior ethmoidal arteries should be sought
and ligated on both sides. Posterior ethmoidal arteries also should
be drilled out and ligated. Image guidance is used to identigy the
anterior and posterior extent of the mass. The anterior cut is
usually made at the level of posterior wall of frontal sinus and
continued along the fovea ethmoidalis using drills and kerrison
punch. The posterior resection is made as posterior as possible.
This is usually governed by the posterior extent of the mass. It can
be as posterior as the planum of sphenoid.
Dura is incised exposing the entire
olfactory groove meningioma. Dissection is completed using a
combination of blunt dissection, debrider and CUSA. Tumors involving
the medial wall of the orbit may be considered to be rather
suboptimal for endoscopic resection. While performing the resection
of the tumor care should be exercised to dissect it between the tumor
and arachnoid plane. The defect in the skull base is repaired using
abdominal fat, reinforced with fascia lata and tissue glue is used to
fix them in place.
Advantages of endoscopic approach:
The main site of recurrence i.e.
The floor of the anterior cranial fossa is completely resected /
drilled out.
Allows two surgeons to operate
simultaneously there by ensuring clear surgical field
Very useful from the cosmetic
point of view.
Role of irradiation in the management
of meningiomas:
RT is indicated only in patients
with recurrent tumors following surgical resection
In patients with atypical /
malignant meningiomas after surgical extirpation of the tumor
Role of stereotactic radio surgery:
The major advantage of this procedure
is that the irradiation dose at the edge of the neoplasm is greatly
reduced thereby sparing the normal adjacent tissues. This procedure
can be safely used to treat even large volume tumors close to
critical intracranial structures.
Targetted molecular therapy:
This type of therapy aims at blocking
the various signals leading to unbridled proliferation of cells.
These include:
Inhibitor of PDGFR – This is
infact a key driver of cell proliferation in meningiomas. Drugs
that block this can help in arresting the growth of meningiomas.
Classic example of these drugs is Imatinib.
Inhibitors of angiogenesis factor
– Sorafenib and Sunitinib are examples of drugs belonging to this
group